Trials / Unknown
UnknownNCT05550766
Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma
Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma: An Immunohistochemical Study.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Vitamin D has a crucial role in cancer control and prevention.vitamin D receptor (VDR) and its heterodimer Retinoid X receptor (RXR) are equally important in the cell. This ligand (vitamin D) and receptors (VDR-RXR) complex together triggers downstream DNA damage response in the cell. Retinoid receptors are a superfamily of nuclear receptors. The preferred receptor that attaches to VDR is RXR, with its subunits α, β and γ. RXR α is more frequent in the skin than other tissues, while β occurs in internal organs and γ is frequently related to neural disorders. the investigator hopes to assess prognosis of SCC \& BCC by using RXR-α biomarker \& attempts to use it in the treatment.
Conditions
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-09-01
- Completion
- 2023-12-01
- First posted
- 2022-09-22
- Last updated
- 2022-09-22
Source: ClinicalTrials.gov record NCT05550766. Inclusion in this directory is not an endorsement.